Inventor · disambiguated record
Mary Haas
Also filed as: HAAS MARY · HAAS MARY E
2 granted patents·6 pending applications·0 citations·filing 2021–2024
31Inventor score
Files withREGENERON PHARMA8
Top patents by PatentIndex Score
8 records- 0175US2024376471A1Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0271US12018259B2Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitorsREGENERON PHARMA·Filed 2021·Granted Jun 25, 2024·0 cites·22 claims
- 0370US11773393B2Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitorsREGENERON PHARMA·Filed 2022·Granted Oct 3, 2023·0 cites·27 claims
- 0464US2024158795A1Treatment Of Kidney Diseases With A Combination of Angiopoietin Like 3 (ANGPTL3) Inhibitors And Solute Carrier Family 5 Member 2 (SLC5A2) InhibitorsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0563US2025092396A1Treatment Of Osteoarthritis With Cartilage Intermediate Layer Protein 2 (CILP2) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0661US2025129372A1Treatment Of Osteoarthritis With Procollagen Galactosyl Transferase 2 (COLGALT2) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0761US2023193271A1Treatment Of Kidney Diseases With Angiopoietin Like 3 (ANGPTL3) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0856US2023107173A1Methods Of Treating Chronic Kidney Disease (CKD) With Inhibitors Of Protective Loss-Of-Function GenesREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mary Haas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →